Differential inclusion of NEB exons 143 and 144 provides insight into NEB-related myopathy variant interpretation and disease manifestation.


Journal

HGG advances
ISSN: 2666-2477
Titre abrégé: HGG Adv
Pays: United States
ID NLM: 101772885

Informations de publication

Date de publication:
23 Sep 2024
Historique:
received: 17 06 2024
revised: 20 09 2024
accepted: 20 09 2024
medline: 25 9 2024
pubmed: 25 9 2024
entrez: 25 9 2024
Statut: aheadofprint

Résumé

Biallelic pathogenic variants in the gene encoding nebulin (NEB) are a known cause of congenital myopathy. We present two brothers with congenital myopathy and compound heterozygous variants (NC_000002.12:g.151692086G>T; NM_001271208.2: c.2079C>A; p.(Cys693Ter) and NC_000002.12:g.151533439T>C; NM_001271208.2:c.21522+3A>G ) in NEB. Transcriptomic sequencing on affected individual muscle revealed that the extended splice variant c.21522+3A>G causes exon 144 skipping. Nebulin isoforms containing exon 144 are known to be mutually exclusive with isoforms containing exon 143, and these isoforms are differentially expressed during development and in adult skeletal muscles. Affected individuals MRI patterns of muscle involvement were compared to the known pattern of relative abundance of these two isoforms in muscle. We propose that the pattern of muscle involvement in these affected individuals better fits the distribution of exon 144-containing isoforms in muscle than with previously published MRI findings in NEB-related disease due to other variants. Our report introduces disease pathogenesis and manifestation as a result of alteration of isoform distributions in muscle.

Identifiants

pubmed: 39318092
pii: S2666-2477(24)00094-0
doi: 10.1016/j.xhgg.2024.100354
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100354

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Sarah Silverstein (S)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA; Rutgers New Jersey School of Medicine, 185 S Orange Ave Newark NJ 07103 USA; Undiagnosed Diseases Program, National Human Genome Research Institute, National Institute of Health, Bethesda, Maryland 20892, USA. Electronic address: sarah.silverstein@nih.gov.

Rotem Orbach (R)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.

Safoora Syeda (S)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.

A Reghan Foley (AR)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.

Svetlana Gorokhova (S)

Aix Marseille Univ, INSERM, MMG, U 1251, Marseille, France; Department of Medical Genetics, Timone Children's Hospital, APHM, Marseille, France.

Katherine G Meilleur (KG)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA; Ionis Pharmaceuticals, Carlsbad CA, USA.

Meganne E Leach (ME)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA; Division of Neurology, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR.

Prech Uapinyoying (P)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA; Research Center for Genetic Medicine, Children's National Research Institute, Children's National Medical Center, Washington DC 20010.

Katherine R Chao (KR)

Broad Institute of MIT and Harvard, 415 Main St. Cambridge MA 02142.

Sandra Donkervoort (S)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.

Carsten G Bönnemann (CG)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA. Electronic address: carsten.bonnemann@nih.gov.

Classifications MeSH